The index provider MSCI is the world's leading provider of indexes. MSCI reviews its indices every six months, and the most recent revision was made in November. Probi is one of the companies selected to be included in the MSCI World Micro Cap Index as of November 30, 2021.
The MSCI World Micro Cap Index consists of over 6,000 companies from 23 stock markets in the world, of which the Health Care segment accounts for approximately 12.5 percent.
"It is a mark of quality to be included in MSCI's index. Probi has not previously been included in the MSCI World Micro Cap Index and we see it as proof of Probi's quality as a company to now be selected. Probi has a long history of good growth and stable profitability, and we are pleased that our work is valued by being included in this global index.", Says Tom Rönnlund, CEO of Probi AB.
For further information, please contact:
Henrik Lundkvist, CFO, Probi,
Phone +46 46 286 89 41, E-mail: email@example.com
Probi[®] is a global company focused exclusively on researching, manufacturing, and delivering probiotics for supplements and functional food. The company is an expert in managing stable, live bacteria from research through every stage of the manufacturing process and are dedicated to making the health-enhancing benefits of probiotics available to people everywhere. Since the company was founded in 1991 at Lund University in Sweden, Probi has expanded its operations to more than 40 markets and holds more than 400 patents worldwide. Probi had sales of SEK 717 m in 2020. Probi's shares are listed on Nasdaq Stockholm, Mid-cap. and there were around 4,000 shareholders on December 31, 2020.
This information was distributed by Cision http://www.cisionwire.se/